The Medincell SAIVE study found that "ivermectin administered for 28 days demonstrated acceptable safety and tolerability without any unexpected safety signals."
The Medincell SAIVE study found that "ivermectin administered for 28 days demonstrated acceptable safety and tolerability without any unexpected safety signals."